Delivery Order SPE2DB24D2010-SPE2DB25FAAXC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $30,912.13. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $9,242.11 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) with a ceiling value of $4,362.15. This competitively awarded, non-set-aside contract was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and is structured as a firm fixed price delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,310.34 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) under a firm fixed price contract. This delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a small-value transaction for pharmaceutical supply to support federal medical procurement needs. The award was made on a non-set-aside, competitive basis, with performance occurring at the contractor's...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 100 mg capsules (100-count) on August 19, 2025, with a ceiling value of $2,284.57 and an ultimate completion date of August 20, 2025. This non-competed, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $3,439.80. This non-set-aside delivery order will be completed by August 5, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $1,013.23. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The contract is...
- The Defense Logistics Agency awarded a delivery order valued at $14,740.75 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAXCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on August 20, 2025, with a ceiling value of $4,312.01 and a firm fixed price structure. This non-set-aside delivery order is expected to be completed by August 21, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement to support federal medical supply needs, leveraging the contractor's established relationship with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.9 billion and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, supplying a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's primary IDC enables flexible fulfillment of pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/20/25 |